Vitamin K2 improves bone strength in postmenopausal women

International Congress Series

Volumn 1297, Issue , 2007, Pages 179-187

  Schurgers, L J ^a   Knapen, M H J ^b   Vermeer, C ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Bone geometry; Gammacarboxyglutamate; Gla; Hip fracture; Menaquinone; Osteocalcin

Indexed keywords

EID: 33947510213     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2006.08.006     Document Type: Article

References (37)

1. Berkner K.L., and Runge K.W. The physiology of vitamin K nutritire and vitamin K-dependent protein function in atherosclerosis. J. Thromb. Haemostas. 2 (2004) 2118-2132
2. Shearer M.J. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr. Opin. Clin. Nutr. Metab. Care 3 (2000) 433-438
3. Price P.A., et al. Characterization of a gammacarboxyglutamic acid-containing protein from bone. Proc. Natl. Acad. Sci. U. S. A. 73 (1976) 1447-1451
4. Hauschka P.V., Lian J.B., and Gallop P. Direct identification of the calcium-binding amino acid gamma-carboxyglutamic acid in mineralized tissue. Proc. Natl. Acad. Sci. U. S. A. 72 (1975) 3925-3929
5. Knapen M.H.J., et al. Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause. Calcif. Tissue Int. 63 (1998) 375-379
6. Sokoll L.J., et al. Diurnal variation in total and undercarboxylated osteocalcin: influence of increased dietary phylloquinone. Calcif. Tissue Int. 62 (1998) 447-452
7. Booth S.L., and Suttie J.W. Dietary intake and adequacy of vitamin K. J. Nutr. 128 (1998) 785-788
8. Sokoll L.J., et al. Changes in serum osteocalcin, plasma phylloquinone, and urinary γ-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am. J. Clin. Nutr. 65 (1997) 779-784
9. Shearer M.J., and Bolton-Smith C. The U.K. food data-base for vitamin K and why we need it. Food Chem. 68 (2000) 213-218
10. Booth S.L., et al. Vitamin K1 (phylloquinone) content of foods: a provisional table. J. Food Compos. Anal. 6 (1993) 109-120
11. Schurgers L.J., et al. Novel conformation-specific antibodies against matrix Gla-protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1629-1633
12. 1 levels in fractured neck of femur. Lancet ii (1984) 83
13. Szulc P., et al. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J. Clin. Invest. 91 (1993) 1769-1774
14. Szulc P., et al. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 18 (1996) 487-488
15. Luukinen H., et al. Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J. Bone Miner. Res. 15 (2000) 2473-2478
16. Feskanich D., et al. Vitamin K intake and hip fractures in women: a prospective study. Am. J. Clin. Nutr. 69 (1999) 74-79
17. Booth S.L., et al. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am. J. Clin. Nutr. 71 (2000) 1201-1208
18. Hart J.P., et al. Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis. J. Clin. Endocrinol. Metab. 60 (1985) 1268-1269
19. Szulc P., et al. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J. Bone Miner. Res. 9 (1994) 1591-1595
20. Booth S.L., et al. Vitamin K intake and bone mineral density in women and men. Am. J. Clin. Nutr. 77 (2003) 512-516
21. Karlamangla A.S., et al. Hip fracture risk assessment using composite indices of femur neck strength: the Rancho Bernardo study. Osteoporos. Int. 15 (2004) 62-70
22. Braam L.A.J.L., et al. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif. Tissue Int. 73 (2003) 21-26
23. Braam L.A.J.L., et al. Factors affecting bone loss in female endurance athletes: a two-year follow-up study. Am. J. Sports Med. 31 (2003) 889-895
24. 1), vitamin D and calcium: effect on bone mineral content. Ann. Nutr. Metab. 45 suppl. 1 (2001) 246
25. 2 on osteoporosis. Curr. Pharm. Des. 10 (2004) 2557-2576
26. 3 as cofactors for the hepatic vitamin K-dependent carboxylase. Biochim. Biophys. Acta 1034 (1990) 170-175
27. Frith J.C., and Rogers M.J. Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro. J. Bone Miner. Res. 18 (2003) 204-212
28. Kenis H., et al. Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry. J. Biol. Chem. 279 (2004) 52623-52629
29. Rogers M.J., et al. Bisphosphonates induce apoptosis in mouse macrophage-like cells by a nitric-oxide-independent mechanism. J. Bone Miner. Res. 11 (1996) 1482-1491
30. 2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J. Biol. Chem. 278 (2003) 43919-43927
31. Ichikawa T., et al. Steroid and xenobiotic receptor SXR mediates vitamin K2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells. J. Biol. Chem. 281 (2006) 16927-16934
32. Katsuyama H., et al. Menaquinone-7 regulates the expression of osteocalcin, OPG, RANKL and RANK in osteoblastic MC3T3E1 cells. Int. J. Mol. Med. 15 (2005) 231-236
33. Schurgers L.J., and Vermeer C. Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim. Biophys. Acta 1570 (2002) 27-32
34. Ronden J.E., Thijssen H.H.W., and Vermeer C. Tissue distribution of K-vitamers under different nutritional regimens in the rat. Biochim. Biophys. Acta 1379 (1998) 16-22
35. Gijsbers B.L.M.G., Jie K.-S.G., and Vermeer C. Effect of food composition on vitamin K absorption in human volunteers. Br. J. Nutr. 76 (1996) 223-229
36. Hodges S.J., et al. Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone 12 (1991) 387-389
37. Geleijnse J.M., et al. Dietary intake of vitamin K-2 reduces the risk of cardiac events and aortic atherosclerosis: The Rotterdam Study. J. Nutr. 134 (2004) 3100-3105